Managers / Q3 2022 · view latest →
STARR INTERNATIONAL CO INC
CIK 0001236615 · 101 BAARERSTRASSE, ZUG, V8, CH-6300 · (4141) 768-9797
Summary
Starr International Co Inc reported $48M in U.S.-listed holdings across 3 positions for Q3 2022.
The portfolio is heavily concentrated: Celularity alone accounts for 73.5% of reported value.
The book was largely unchanged from Q2 2022.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 73.5% · $35M
- Common Stock · 26.5% · $13M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BCSFBAIN CAPITAL SPECIALTY FINANCE ORD | HELD | +10.7K | 824.5K | −$1M | $10M |
| CELULARITY INC. | HELD | +0 | 15.28M | −$17M | $35M |
| AIGAMERICAN INTERNATIONAL GROUP ORD | HELD | +0 | 59.0K | −$216,000 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CELULARITY INC. | COM STK | 73.55% | $35M | 15.28M |
| 2 | BCSFBAIN CAPITAL SPECIALTY FINANCE ORDhistory → | COM STK | 20.61% | $10M | 824.5K |
| 3 | AIGAMERICAN INTERNATIONAL GROUP ORDhistory → | COM STK | 5.84% | $3M | 59.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $20M | 3 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | Under review | 3 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $20M | 3 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 3 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $48M | 3 | Oct 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $66M | 3 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $149M | 3 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $60M | 3 | Jan 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $50M | 5 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $40M | 5 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $31M | 5 | Apr 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $27M | 5 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $22M | 5 | Oct 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $13M | 3 | Jul 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $139M | 33 | Apr 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $204M | 29 | Jan 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $228M | 42 | Oct 11, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $240M | 35 | Jul 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $251M | 113 | Apr 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $121M | 21 | Feb 1, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.